Logo image of MASK

3 E NETWORK TECHNOLOGY GRP-A (MASK) Stock Fundamental Analysis

NASDAQ:MASK - VGG8849D1107 - Common Stock

0.62 USD
-0.03 (-4.62%)
Last: 8/28/2025, 2:51:14 PM
Fundamental Rating

5

MASK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 83 industry peers in the IT Services industry. MASK has an excellent financial health rating, but there are some minor concerns on its profitability. MASK is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year MASK was profitable.
In the past year MASK had a positive cash flow from operations.
MASK Yearly Net Income VS EBIT VS OCF VS FCFMASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M 1.5M

1.2 Ratios

With an excellent Return On Assets value of 48.78%, MASK belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
MASK has a Return On Equity of 69.00%. This is amongst the best in the industry. MASK outperforms 96.39% of its industry peers.
MASK's Return On Invested Capital of 69.88% is amongst the best of the industry. MASK outperforms 98.80% of its industry peers.
MASK had an Average Return On Invested Capital over the past 3 years of 54.72%. This is significantly above the industry average of 22.12%.
The 3 year average ROIC (54.72%) for MASK is below the current ROIC(69.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 48.78%
ROE 69%
ROIC 69.88%
ROA(3y)38.06%
ROA(5y)N/A
ROE(3y)95.71%
ROE(5y)N/A
ROIC(3y)54.72%
ROIC(5y)N/A
MASK Yearly ROA, ROE, ROICMASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 50 100

1.3 Margins

Looking at the Profit Margin, with a value of 34.04%, MASK belongs to the top of the industry, outperforming 97.59% of the companies in the same industry.
Looking at the Operating Margin, with a value of 39.71%, MASK belongs to the top of the industry, outperforming 98.80% of the companies in the same industry.
Looking at the Gross Margin, with a value of 50.69%, MASK is in the better half of the industry, outperforming 73.49% of the companies in the same industry.
Industry RankSector Rank
OM 39.71%
PM (TTM) 34.04%
GM 50.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MASK Yearly Profit, Operating, Gross MarginsMASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MASK is creating value.
The number of shares outstanding for MASK remains at a similar level compared to 1 year ago.
The debt/assets ratio for MASK has been reduced compared to a year ago.
MASK Yearly Shares OutstandingMASK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
MASK Yearly Total Debt VS Total AssetsMASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 7.52 indicates that MASK is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.52, MASK belongs to the top of the industry, outperforming 87.95% of the companies in the same industry.
MASK has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.13, MASK belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that MASK is not too dependend on debt financing.
MASK has a Debt to Equity ratio of 0.02. This is in the better half of the industry: MASK outperforms 79.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.13
Altman-Z 7.52
ROIC/WACC7.43
WACC9.4%
MASK Yearly LT Debt VS Equity VS FCFMASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

MASK has a Current Ratio of 2.14. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.14, MASK is doing good in the industry, outperforming 62.65% of the companies in the same industry.
A Quick Ratio of 2.14 indicates that MASK has no problem at all paying its short term obligations.
MASK has a Quick ratio of 2.14. This is in the better half of the industry: MASK outperforms 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.14
MASK Yearly Current Assets VS Current LiabilitesMASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.30% over the past year.
Looking at the last year, MASK shows a very strong growth in Revenue. The Revenue has grown by 172.94%.
EPS 1Y (TTM)55.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.65%
Revenue 1Y (TTM)172.94%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MASK Yearly Revenue VS EstimatesMASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.70, which indicates a rather cheap valuation of MASK.
Based on the Price/Earnings ratio, MASK is valued cheaply inside the industry as 98.80% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MASK to the average of the S&P500 Index (27.14), we can say MASK is valued rather cheaply.
Industry RankSector Rank
PE 2.7
Fwd PE N/A
MASK Price Earnings VS Forward Price EarningsMASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MASK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MASK is cheaper than 97.59% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MASK is valued cheaper than 96.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.26
EV/EBITDA 2.42
MASK Per share dataMASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

The decent profitability rating of MASK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MASK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

3 E NETWORK TECHNOLOGY GRP-A

NASDAQ:MASK (8/28/2025, 2:51:14 PM)

0.62

-0.03 (-4.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.89%
Inst Owner ChangeN/A
Ins Owners68.44%
Ins Owner ChangeN/A
Market Cap6.97M
AnalystsN/A
Price TargetN/A
Short Float %2.05%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.7
Fwd PE N/A
P/S 0.91
P/FCF 6.26
P/OCF 6.26
P/B 1.84
P/tB 1.84
EV/EBITDA 2.42
EPS(TTM)0.23
EY37.1%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY15.97%
OCF(TTM)0.1
OCFY15.97%
SpS0.68
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 48.78%
ROE 69%
ROCE 78.73%
ROIC 69.88%
ROICexc 71.2%
ROICexgc 71.2%
OM 39.71%
PM (TTM) 34.04%
GM 50.69%
FCFM 14.49%
ROA(3y)38.06%
ROA(5y)N/A
ROE(3y)95.71%
ROE(5y)N/A
ROIC(3y)54.72%
ROIC(5y)N/A
ROICexc(3y)56.67%
ROICexc(5y)N/A
ROICexgc(3y)56.67%
ROICexgc(5y)N/A
ROCE(3y)61.65%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.13
Debt/EBITDA 0.03
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 36.41%
Profit Quality 42.57%
Current Ratio 2.14
Quick Ratio 2.14
Altman-Z 7.52
F-Score5
WACC9.4%
ROIC/WACC7.43
Cap/Depr(3y)97.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.14%
Cap/Sales(5y)N/A
Profit Quality(3y)109.93%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)172.94%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.48%
OCF growth 3YN/A
OCF growth 5YN/A